According to Incyte's latest financial reports the company's total debt is $38.28 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $38.28 M | -7.65% |
2022-12-31 | $41.45 M | -7.51% |
2021-12-31 | $44.82 M | -5.7% |
2020-12-31 | $47.53 M | -21.08% |
2019-12-31 | $60.22 M | 66.69% |
2018-12-31 | $36.13 M | 50.54% |
2017-12-31 | $24 M | -96.32% |
2016-12-31 | $0.65 B | 5.1% |
2015-12-31 | $0.61 B | -8.19% |
2014-12-31 | $0.67 B | 2.06% |
2013-12-31 | $0.66 B | 99.82% |
2012-12-31 | $0.33 B | 4.72% |
2011-12-31 | $0.31 B | 7.74% |
2010-12-31 | $0.29 B | -33.78% |
2009-12-31 | $0.44 B | 11.86% |
2008-12-31 | $0.39 B | 2.49% |
2007-12-31 | $0.38 B | 4.16% |
2006-12-31 | $0.37 B | 8.55% |
2005-12-31 | $0.34 B | -9.74% |
2004-12-31 | $0.37 B | 125.74% |
2003-12-31 | $0.16 B | -2.47% |
2002-12-31 | $0.17 B | -4.02% |
2001-12-31 | $0.17 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Novartis NVS | $26.34 B | 68,717.09% | ๐จ๐ญ Switzerland |
Pfizer PFE | $70.84 B | 184,936.70% | ๐บ๐ธ USA |
Eli Lilly LLY | $25.22 B | 65,784.77% | ๐บ๐ธ USA |
Amgen AMGN | $64.61 B | 168,659.63% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $6.16 M | -83.90% | ๐บ๐ธ USA |
Geron GERN | $85.89 M | 124.36% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | $48.89 M | 27.71% | ๐บ๐ธ USA |
AVEO Oncology
AVEO | $38.68 M | 1.03% | ๐บ๐ธ USA |
Ardelyx ARDX | $55.98 M | 46.22% | ๐บ๐ธ USA |